Judgment – Medicinal products for human use – Marketing authorisation for the generic medicinal product Zoledronic acid Teva Pharma – zoledronic acid – Regulatory data protection period for the reference medicinal products Zometa and Aclasta, containing the active substance zoledronic acid – Directive 2001/83/EC – Regulation (EEC) No 2309/93 and Regulation (EC) No 726/2004 – Global marketing authorisation – Regulatory data protection period)
T-472/12, [2015] EUECJ T-472/12, ECLI:EU:T:2015:637
Bailii
European
European
Updated: 04 January 2022; Ref: scu.552372
